acucela inc (4589:Tokyo Stock Exchange)
David G. Birch Ph.D.
|Age||Total Calculated Compensation||This person is connected to 37 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. David G. Birch, Ph.D., serves as an Advisor of Acucela Inc. Dr. Birch serves as Member of Ophthalmology Clinical Advisory Board of Bioaxone Therapeutic Inc. Dr. Birch serves as Research Director of Retina Foundation of the Southwest, and Adjunct Professor of Dept of Ophthalmology of UT Southwestern Medical Center, Dallas, Texas. He serves as Member of Ophthalmology Scientific Advisory Board of Applied Genetic Technologies Corporation. He has been a consultant to ...
1301 Second AvenuePhone: 206-805-8300
Seattle, Washington 98101
Board Members Memberships*There is no Board Members Memberships data available.
University of California
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.